Oxidative stress in patients with essential hypertension: A comparison of dippers and non-dippers

European Journal of Internal Medicine

Volumn 24, Issue 2, 2013, Pages 139-144

  Gönenç, Aymelek ^a   Hacişevki, Aysun ^a   Tavil, Yusuf ^a   Çengel, Atiye ^a   Torun, Meral ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Asymmetric dimethyl arginine; Dipper; Malondialdehyde; Nitrotyrosine; Non dipper; Total antioxidant capacity

Indexed keywords

3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; ANTIOXIDANT; BIOLOGICAL MARKER; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; TRIACYLGLYCEROL; UBIDECARENONE;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESSENTIAL HYPERTENSION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

ANTIOXIDANTS; ARGININE; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYPERTENSION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; TYROSINE;

EID: 84873720830     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2012.08.016     Document Type: Article

References (44)

1. A.D. Lopez, C.D. Mathers, M. Ezzati, D.T. Jamison, and C.J. Murray Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data Lancet 367 2006 1747 1757
2. I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, and R. Cifkova European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) Eur J Cardiovasc Prev Rehabil 14 2007 S1 S113
3. S.K. Nadar, M.H. Tayebjee, F. Messerli, and G.Y. Lip Target organ damage in hypertension: pathophysiology and implications for drug therapy Curr Pharm Des 12 2006 1581 1592
4. E.S. Muxfeldt, and G.F. Salles Pulse pressure or dipping pattern: which one is a better cardiovascular risk marker in resistant hypertension? J Hypertens 26 2008 878 884
5. P. Verdecchia, G. Schillaci, and C. Porcellati Dippers versus non-dippers J Hypertens 9 1991 42 48
6. M. Fukuda, M. Munemura, T. Usami, N. Nakao, O. Takeuchi, and Y. Kamiya Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy Kidney Int 65 2004 621 625
7. H.S. Seo, T.S. Kang, S. Park, E.Y. Choi, Y.G. Ko, and D. Choi Non-dippers are associated with adverse cardiac remodeling and dysfunction Int J Cardiol 112 2006 171 177
8. A. Ceriello Possible role of oxidative stress in the pathogenesis of hypertension Diabetes Care 31 2008 S181 S184
9. L.O. Lerman, and A.R. Chade Atherosclerotic process, renovascular disease and outcomes from bench to bedside Curr Opin Nephrol Hypertens 15 2006 583 587
10. H. Cai, and D.G. Harrison Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress Circ Res 87 2000 840 844
11. S.S. Bessa, E.M.M. Ali, and S.M. Hamdy The role of glutathione S-transferase M1 and T1 gene polymorphisms and oxidative stress-related parameters in Egyptian patients with essential hypertension Eur J Intern Med 20 2009 625 630
12. J. de Champlain, R. Wu, H. Girouard, M. Karas, A.E. Midaoui, and M. Laplante Oxidative stress in hypertension Clin Exp Hypertens 26 2004 593 601
13. R. Rodrigo, J. González, and F. Paoletto The role of oxidative stress in the pathophysiology of hypertension Hypertens Res 34 2011 431 440
14. L. Sun, Y.-H. Gao, D.-K. Tian, J.-P. Zheng, C.-Y. Zhu, and Y. Ke Inflammation of different tissues in spontaneously hypertensive rats Acta Physiol Sin 58 2006 318 323
15. A. YIldIz, M. Gur, R. Demirbag, R. YIlmaz, S. Akyol, and M. Aslan Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients Clin Biochem 41 2008 779 784
16. J. Nourooz-Zadeh, J. Tajaddini-Sarmadi, and S.P. Wolff Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine Anal Biochem 220 1994 403 409
17. R. Re, N. Pellegrini, A. Proteggente, A. Pannala, M. Yang, and C. Rice-Evans Antioxidant activity applying an improved ABTS radical cation decolorization assay Free Radic Biol Med 26 1999 1231 1237
18. E. Teran, M. Racines-Orbe, S. Vivero, C. Escudero, G. Molina, and A. Calle Preeclampsia is associated with a decrease in plasma coenzyme Q10 levels Free Radic Biol Med 35 2003 1453 1456
19. H. Ischiropoulos, and J.S. Beckman Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 111 2003 163 169
20. F.J. Schopfer, P.R. Baker, and B.A. Freeman NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response? Trends Biochem Sci 28 2003 646 654
21. N.S. Dhalla, R.M. Temsah, and T. Netticadan Role of oxidative stress in cardiovascular diseases J Hypertens 18 2000 655 673
22. R.M. Touyz, and E.L. Schiffrin Reactive oxygen species in vascular biology:Implications in hypertension Histochem Cell Biol 122 2004 339 352
23. F. Nielsen, B.B. Mikkelsen, J.B. Nielsen, H.R. Andersen, and P. Grandjean Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors Clin Chem 43 1997 1209 1214
24. M.K. Kashyap, V. Yadav, B.S. Sherawat, S. Jain, S. Kumari, and M. Khullar Different antioxidants status, total antioxidant power and free radicals in essential hypertension Mol Cell Biochem 277 2005 89 99
25. R. Rodrigo, H. Prat, W. Passalacqua, J. Araya, C. Guichard, and J.P. Bächler Relationship between oxidative stress and essential hypertension Hypertens Res 30 2007 1159 1167
26. J. Cracowski, T. Durand, and G. Bessard Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications Trends Pharmacol Sci 23 2002 360
27. N.D. Vaziri, Z. Ni, F. Oveisi, and D.L. Trnavsky-Hobbs Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats Hypertension 36 2000 957 964
28. G. Zalba, G. San Jose, M.U. Moreno, M.A. Fortuño, A. Fortuño, and F.J. Beaumont Oxidative stress in arterial hypertension: role of NAD(P)H oxidase Hypertension 38 2001 1395 1399
29. E. Grossman Does increased oxidative stress cause hypertension? Diabetes Care 31 2008 S185 S189
30. M. Beg, A. Gupta, and V.N. Khanna Oxidative stress in essential hypertension and role of antioxidants JIACM 11 2010 287 293
31. A. Çurgunlu, H. Uzun, I. Bavunoǧlu, Y. Karter, H. GenÇ, and S. Vehid Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension J Hum Hypertens 19 2005 629 633
32. C. Napoli, V. Sica, F. de Nigris, O. Pignalosa, M. Condorelli, and L.J. Ignarro Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension Am Heart J 148 2004 148 152
33. R.H. Böger, P. Vallance, and J.P. Cooke Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase Atheroscler Suppl 4 2003 1 3
34. S. Takiuchi, H. Fujii, K. Kamide, T. Horio, S. Nakatani, and A. Hiuge Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients Am J Hypertens 17 2004 802 808
35. A. Güngör, Y. AydIn, G. Celbek, C. Başar, R. Alemdar, and S. Ordu Asymmetric dimethylarginine levels in dipper and nondipper hypertensive patients Dicle Med J 37 2010 332 338
36. T.J. Guzik, N.E. West, R. Pillai, D.P. Taggart, and K.M. Channon Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels Hypertension 39 2002 1088 1094
37. L. Kalinowski, I.T. Dobrucki, and T. Malinski Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases Circulation 109 2004 2511 2517
38. L. Zhou, W. Xiang, J. Potts, M. Floyd, C. Sharan, and H. Yang Reduction in extracellular superoxide dismutase activity in African-American patients with hypertension Free Radic Biol Med 41 2006 1384 1391
39. H. Negishi, K. Ikeda, M. Sagara, M. Sawamura, and Y. Yamori Increased oxidative DNA damage in stroke-prone spontaneously hypertensive rats Clin Exp Pharmacol Physiol 26 1999 482 484
40. A. YIldIz, M. Gür, R. YIlmaz, R. Demirbaǧ, H. Çelik, and M. Aslan Lymphocyte DNA damage and total antioxidant status in patients with white-coat hypertension and sustained hypertension Arch Turk Soc Cardiol 36 2008 231 238
41. G.M. Chisolm, and D. Steinberg The oxidative modification hypothesis of atherogenesis: an overview Free Radic Biol Med 28 2000 1815 1826
42. C. Chrysohoou, D.B. Panagiotakos, C. Pitsavos, J. Skoumas, M. Economou, and L. Papadimitriou The association between pre-hypertension status and oxidative stres markers related to atherosclerotic disease: the ATTICA study Atherosclerosis 192 2007 169 176
43. V. Kagan, E.A. Serbinova, G.M. Koynova, S.A. Kitanova, V. Tyurin, and T.S. Stoytchev Antioxidant action of ubiquinol homologues with different isoprenoid chain length in biomembranes Free Radic Biol Med 9 1990 117 126
44. F.L. Rosenfeldt, S.J. Haas, H. Krum, A. Hadj, K. Ng, and J.Y. Leong Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials J Hum Hypertens 21 2007 297 306